Find a Doctor or Practice Location

Medical School: University of California - San Francisco
Residency: Hospital of the University of Pennsylvania
Fellowship: Hospital of the University of Pennsylvania

American College of Chest Physicians, National American Thoracic Society, National Diagnosis and Management of Lung Cancer: American College of Chest Physicians Evidence-based Clinical Practice Guidelines, 3rd Edition (LC III), National International Association for the Study of Lung Cancer, International Laennec Society , Local

Hospital Privileges:

• Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
• Penn Medicine Rittenhouse Long-Term Acute Care Hospital: Has privileges to treat patients in the hospital.
• Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
• Pennsylvania Hospital: Has privileges to treat patients in the hospital.

Selected Publications:

Tanner NT, Porter A, Gould MK, Li XJ, Vachani A, Silvestri GA: Physician Assessment of Pretest Probability of Malignancy and Adherence With Guidelines for Pulmonary Nodule Evaluation. Chest 152 (2): 263-270,2017.

Xu R, Mesaros C, Weng L, Snyder NW, Vachani A, Blair IA, Hwang WT: Comparison of statistical methods for detection of serum lipid biomarkers for mesothelioma and asbestos exposure. Biomarkers in Medicine 11 (7): 547-556,2017.

Schonewolf CA, Verma V, Post CM, Berman AT, Frick MA, Vachani A, Lin C, Simone CB: Outcomes of invasive mediastinal nodal staging versus positron emission tomography staging alone for early-stage non-small cell lung cancer treated with stereotactic body radiation therapy. Lung Cancer (Amsterdam, Netherlands) : 2017.

Bagley SJ, Kothari S, Aggarwal C, Bauml JM, Alley EW, Evans TL, Kosteva JA, Ciunci CA, Gabriel PE, Thompson JC, Stonehouse-Lee S, Sherry VE, Gilbert E, Eaby-Sandy B, Mutale F, DiLullo G, Cohen RB, Vachani A, Langer CJ: Pretreatment neutrophil-to-lymphocyte ratio as a marker of outcomes in nivolumab-treated patients with advanced non-small-cell lung cancer. Lung Cancer (Amsterdam, Netherlands) 106 : 1-7,2017.

Huang J., Liu Y., Vitale S., Penning T.M., Whitehead A.S., Blair I.A., Vachani A., Clapper M., Muscat J.E., Lazarus P., Scheet P., Moore J.H., Chen Y.: On meta- and mega-analyses for gene–environment interactions Genetic Epidemiology (in press) : 2017.

Patnaik SK, Kannisto ED, Mallick R, Vachani A, Yendamuri S: Whole blood microRNA expression may not be useful for screening non-small cell lung cancer. PloS One 12 (7): e0181926,2017.

Frey AJ, Wang Q, Busch C, Feldman D, Bottalico L, Mesaros CA, Blair IA, Vachani A, Snyder NW.: Validation of highly sensitive simultaneous targeted and untargeted analysis of keto-steroids by Girard P derivatization and stable isotope dilution-liquid chromatography-high resolution mass spectrometry. Steroids 116 : 60-66,2016.

Thompson JC, Yee SS, Troxel AB, Savitch SL, Fan R, Balli D, Lieberman DB, Morrissette JD, Evans TL, Bauml J, Aggarwal C, Kosteva JA, Alley E, Ciunci C, Cohen RB, Bagley S, Stonehouse-Lee S, Sherry VE, Gilbert E, Langer C, Vachani A, Carpenter EL: Detection of therapeutically targetable driver and resistance mutations in lung cancer patients by next generation sequencing of cell-free circulating tumor DNA. Clinical Cancer Research 22 (23): 5772-5782,2016.

Schapira MM, Aggarwal C, Akers S, Aysola J, Imbert D, Langer C, Simone CB 2nd, Strittmatter E, Vachani A, Fraenkel L.: How Patients View Lung Cancer Screening: The Role of Uncertainty in Medical Decision Making Ann Am Thorac Soc 13 (11): 1969-1976,2016.

Bagley SJ, Vitale S, Zhang S, Aggarwal C, Evans TL, Alley EW, Cohen RB, Langer CJ, Blair IA, Vachani A, Whitehead AS: Pretreatment Red Blood Cell Total Folate Concentration Is Associated With Response to Pemetrexed in Stage IV Nonsquamous Non-Small-cell Lung Cancer. Clin Lung Cancer 18 (2): e143-e149,2016.

Penn Lung Center website